84 related articles for article (PubMed ID: 3300775)
1. The steroid binding domain of porcine estrogen receptor.
Koike S; Nii A; Sakai M; Muramatsu M
Biochemistry; 1987 May; 26(9):2563-8. PubMed ID: 3300775
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of estrogen receptors covalently labeled with an estrogen and an antiestrogen in several estrogen target cells as studied by limited proteolysis.
Elliston JF; Katzenellenbogen BS
J Steroid Biochem; 1988 Jun; 29(6):559-69. PubMed ID: 3290576
[TBL] [Abstract][Full Text] [Related]
3. Structural analysis of covalently labeled estrogen receptors by limited proteolysis and monoclonal antibody reactivity.
Katzenellenbogen BS; Elliston JF; Monsma FJ; Springer PA; Ziegler YS; Greene GL
Biochemistry; 1987 Apr; 26(8):2364-73. PubMed ID: 3620450
[TBL] [Abstract][Full Text] [Related]
4. Subunit composition of the estrogen receptor. Involvement of the hormone-binding domain in the dimeric state.
Sabbah M; Redeuilh G; Baulieu EE
J Biol Chem; 1989 Feb; 264(5):2397-400. PubMed ID: 2914914
[TBL] [Abstract][Full Text] [Related]
5. Structural characterization of the trypsinized estrogen receptor.
Fritsch M; Anderson I; Gorski J
Biochemistry; 1993 Dec; 32(50):14000-8. PubMed ID: 8268178
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of mouse uterine estrogen receptor under conditions of varying hormonal status.
Horigome T; Golding TS; Quarmby VE; Lubahn DB; McCarty K; Korach KS
Endocrinology; 1987 Dec; 121(6):2099-111. PubMed ID: 3678140
[TBL] [Abstract][Full Text] [Related]
7. Identification of cysteine 530 as the covalent attachment site of an affinity-labeling estrogen (ketononestrol aziridine) and antiestrogen (tamoxifen aziridine) in the human estrogen receptor.
Harlow KW; Smith DN; Katzenellenbogen JA; Greene GL; Katzenellenbogen BS
J Biol Chem; 1989 Oct; 264(29):17476-85. PubMed ID: 2793867
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of estrogen receptor turnover in uterine cells in vitro and in uteri in vivo.
Nardulli AM; Katzenellenbogen BS
Endocrinology; 1986 Nov; 119(5):2038-46. PubMed ID: 3533520
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
Attardi B; Happe HK
Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150
[TBL] [Abstract][Full Text] [Related]
10. Multiple forms of affinity-labeled estrogen receptors in rat distinct pituitary cells.
Geffroy-Roisne S; Duval J; Thieulant ML
Endocrinology; 1992 Sep; 131(3):1503-10. PubMed ID: 1505480
[TBL] [Abstract][Full Text] [Related]
11. The interaction site for tamoxifen aziridine with the bovine estrogen receptor.
Ratajczak T; Wilkinson SP; Brockway MJ; Hähnel R; Moritz RL; Begg GS; Simpson RJ
J Biol Chem; 1989 Aug; 264(23):13453-9. PubMed ID: 2760029
[TBL] [Abstract][Full Text] [Related]
12. Nuclear estrogen receptor molecular heterogeneity in the mouse uterus.
Golding TS; Korach KS
Proc Natl Acad Sci U S A; 1988 Jan; 85(1):69-73. PubMed ID: 3422428
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization by mass spectrometry of the human estrogen receptor ligand-binding domain expressed in Escherichia coli.
Seielstad DA; Carlson KE; Katzenellenbogen JA; Kushner PJ; Greene GL
Mol Endocrinol; 1995 Jun; 9(6):647-58. PubMed ID: 8592511
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen aziridine labeling of the estrogen receptor-potential utility in detecting biologically aggressive breast tumors.
Trivedi S; Piccart M; Muquardt C; Gilot N; Hadiy S; Patel D; Leclercq G
Breast Cancer Res Treat; 1996; 40(3):231-41. PubMed ID: 8883965
[TBL] [Abstract][Full Text] [Related]
15. Efficient and highly selective covalent labeling of the estrogen receptor with [3H]tamoxifen aziridine.
Katzenellenbogen JA; Carlson KE; Heiman DF; Robertson DW; Wei LL; Katzenellenbogen BS
J Biol Chem; 1983 Mar; 258(6):3487-95. PubMed ID: 6833211
[No Abstract] [Full Text] [Related]
16. Localization of the estrogen receptor in uterine cells by affinity labeling with [3H]tamoxifen aziridine.
Ignar-Trowbridge DM; Nelson KG; Ross KA; Washburn TF; Korach KS; McLachlan JA
J Steroid Biochem Mol Biol; 1991 Jul; 39(1):131-2. PubMed ID: 2069860
[TBL] [Abstract][Full Text] [Related]
17. Unique molecular properties of a urea- and salt-stable DNA-binding estrogen receptor dimer covalently labeled with the antiestrogen [3H]desmethylnafoxidine aziridine. A comparison with the estrogen-receptor complex.
Hutchens TW; McNaught RW; Yip TT; Suzuki T; Li CM; Besch PK
Mol Endocrinol; 1990 Feb; 4(2):255-67. PubMed ID: 2330004
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogen.
Monsma FJ; Katzenellenbogen BS; Miller MA; Ziegler YS; Katzenellenbogen JA
Endocrinology; 1984 Jul; 115(1):143-53. PubMed ID: 6734512
[TBL] [Abstract][Full Text] [Related]
19. [125I]iododesethyl tamoxifen aziridine: synthesis and covalent labeling of the estrogen receptor with an iodine-labeled affinity label.
Salituro FG; Carlson KE; Elliston JF; Katzenellenbogen BS; Katzenellenbogen JA
Steroids; 1986; 48(5-6):287-313. PubMed ID: 3445283
[TBL] [Abstract][Full Text] [Related]
20. A ligand-induced conformational change in the estrogen receptor is localized in the steroid binding domain.
Fritsch M; Leary CM; Furlow JD; Ahrens H; Schuh TJ; Mueller GC; Gorski J
Biochemistry; 1992 Jun; 31(23):5303-11. PubMed ID: 1606154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
